Definium director receives RSU and option grants
Definium Therapeutics director Carol A. Vallone received equity-based compensation consisting of restricted stock units and stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Definium Therapeutics director Carol A. Vallone received equity-based compensation consisting of restricted stock units and stock options. She was granted 4,666 RSUs, each representing one common share at no purchase price, bringing her direct holdings to 21,210 common shares.
Vallone also received a stock option covering 19,188 common shares at an exercise price of $24.11 per share, expiring on June 10, 2036. Both the RSUs and the option vest in 12 equal monthly installments from the grant date, with any remaining unvested portion vesting earlier immediately before the issuer’s next annual meeting if it occurs within the first year, subject to her continued service.
Insider Trade Summary
Grant/Award: 23,854 shares
Grant/Award
2 txns
Insider
Vallone Carol A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 19,188 | $0.00 | $0.00 |
| Grant/Award | Common Shares | 4,666 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 19,188 contracts (Direct);
Common Shares — 21,210 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
- F2. The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Restricted stock units granted: 4,666 shares
Stock options granted: 19,188 shares
Option exercise price: $24.11 per share
+4 more
7 metrics
Restricted stock units granted
4,666 shares
RSU grant to director on June 11, 2026
Stock options granted
19,188 shares
Option grant to director on June 11, 2026
Option exercise price
$24.11 per share
Stock option strike price
Option expiration
June 10, 2036
Stock option expiry date
Shares held after grant
21,210 shares
Director’s direct common share holdings post-transaction
RSU vesting schedule
1/12 monthly
Monthly vesting over 12 months from grant date
Option vesting schedule
1/12 monthly
Monthly vesting over 12 months from grant date
Key Terms
restricted stock units ("RSUs"), Stock Option, contingent right, vests and becomes exercisable, +1 more
5 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option financial
"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
contingent right financial
"Each RSU represents a contingent right to receive one common share of the Issuer"
vests and becomes exercisable financial
"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares"
annual meeting financial
"immediately prior to the Issuer's annual meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Definium Therapeutics (DFTX) grant to director Carol A. Vallone?
Definium Therapeutics granted Carol A. Vallone 4,666 restricted stock units and a stock option for 19,188 common shares. These equity awards were issued as compensation and involve no cash purchase at grant, aligning her incentives with common shareholders.
How do Carol A. Vallone’s RSUs in Definium Therapeutics (DFTX) vest?
Vallone’s 4,666 RSUs vest as to one-twelfth of the underlying shares on each monthly anniversary of the grant date. Any remaining unvested RSUs vest immediately before the next annual meeting if it falls within a year, subject to her continued service.
What are the key terms of Carol A. Vallone’s Definium Therapeutics (DFTX) stock option?
She received a stock option for 19,188 common shares at an exercise price of $24.11 per share, expiring June 10, 2036. The option vests in 12 equal monthly installments from the grant date, contingent on her continued service with the company.
Can Carol A. Vallone’s Definium Therapeutics (DFTX) RSUs vest earlier than monthly installments?
Yes. While RSUs normally vest monthly over 12 months, any unvested RSUs will fully vest immediately before the company’s next annual meeting if it occurs within one year of grant, assuming she remains in service through that vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates